info icon

This is a non-core endpoint: only basic statistics are computed.

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

ST19_TOXIC_EFFECT_HALOGEN_DERIV_ALIPH_AROMA_HYDROCA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 T53
  • Cause of death: ICD-10 T53

2 out of 7 registries used, show all original rules.

8

4. Check minimum number of events

None

8

5. Include endpoints

None

8

6. Filter based on genotype QC (FinnGen only)

8

Control definitions (FinnGen only)

Control exclude
ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T5[1-9]|T6[0-5]
Name in latin
Effectus toxicus derivatorum halogenisatorum hydrocarbonum aliphaticorum et aromaticorum

Similar endpoints

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 8 - 5
Unadjusted period prevalence (%) 0.00 - 0.00
Median age at first event (years) 46.26 - 44.42

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007164) IgA [Mass/volume] in Serum or Plasma
0
18
0.00
0.70
0.0
1.6
—
2.7
—
0
12
(3002385) Erythrocyte distribution width [Ratio]
8
64
+∞
0.47
15.9
14.2
%
13.2
13.6
—
8
64
(40768797) Stomach Pathology biopsy report
0
16
0.00
0.47
0.0
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
11
0.00
0.23
0.0
2.1
—
104.1
—
0
11
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
12
0.00
0.23
0.0
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
8
74
+∞
0.00
12.5
11.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
0.9
—
0
6
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
0
5
0.00
0.00
0.0
1.0
—
1.6
—
0
5
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
1.0
—
6.2
—
0
6
(3005322) IgE [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
299.4
—
0
5
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
1.0
—
4.7
—
0
6
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
5
0.00
0.00
0.0
1.0
—
154.0
—
0
5
(4010399)
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3012544) pH of Venous blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
5
0.00
0.00
0.0
1.4
—
47.0
—
0
5
(3005719) IgG [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
9.7
—
0
6
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
0
6
0.00
0.00
0.0
2.8
—
96.4
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: ST19_TOXIC_EFFECT_HALOGEN_DERIV_ALIPH_AROMA_HYDROCA – Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).